Pressotherapy Systems Market Trends

Growth Drivers

• Positive influence on blood rheology and biochemical markers: The proven ability to improve blood rheology and biochemical markers is effectively driving the clinical implementation and the market growth. As per the September 2024 NLM article, a clinical study was conducted on 15 healthy women aged between 20 and 26 years. They underwent 10 lower limb pressotherapy treatments, each lasting for 30 minutes. The analysis of the study demonstrated rheological parameters ranging from 0.5 to 1.1, 4.2, 15.9, 30.9, and 60.0 indices of blood viscosity, thereby deliberately uplifting the overall market globally.
• Lymphedema incidence as a chronic disease: This particular disease occurs, owing to a surge in lymphatic fluid in the body, resulting in swelling, along with tissue and skin changes, which is positively impacting the market internationally. As per an article published by NLM in April 2023, primary lymphedema is extremely rare, affecting only 1 in 100,000 individuals globally, whereas secondary lymphedema is one of the common causes of the disease, and 1 in 1,000 people in America are affected. Besides, the case of head and neck cancer, soft and lymphatic tissue complications commence in first 18 months, and 90% of patients experience internal and external lymphedema, thus enhancing the demand for the market.
• Medicare policy shift and technical accessibility: The aspect of changes in reimbursement and regulations has increased the adoption of innovation for the market across different nations. For instance, as per the 2023 CMS report, NeuroNode utilizes the body’s 3D spatial movements to provide suitable control of therapy devices. These movements can be effectively detected even if there has been a reduction in the muscle’s ability to contract by an estimated 95%. Besides, there has been the provision of a two-metal radiation protection solution, which is available across 40% of hospitals in America, thereby denoting an optimistic approach for the market expansion.

Global Presence of Ischaemic Heart Disease Driving the Pressotherapy Market Demand

International Premature Death Probability Among Women, 2024

Source: NLM, January 2024

Gross Domestic Product (GDP) Impacting the Market

Proportion of Countries in Regions’ GDP Spend on Health, 2024

Source: NLM, January 2024

Challenges

• Complicated approvals and delays in regulations: The international market is readily suffering from a lengthy and fragmented administrative pathway. The aspect of continuous transition in regulatory policies has developed a series backlogs for CE certifications, which is negatively impacting the overall market. Besides, these delays are especially affecting small-scale manufacturers, who are witnessing MDR complexity. However, the FDA’s Breakthrough Device program is the ultimate solution to diminish long approval duration, particularly for innovative and cutting-edge systems like that of pressotherapy.
• Restricted insurance coverage: The presence of barriers in insurance coverage has developed substantial market accessibility gaps, which are negatively impacting the market globally. In developing economies, the situation is worse since pressotherapy devices have been excluded from public health coverage, especially across countries in Southeast Asia and Africa. This coverage barrier has resulted in clinical consequences, leading to uninsured patients and discontinuation of treatments, thus lowering the market’s exposure.